MELISSA FLUHARTY: Open Payments
NPI 1457827768 · MARIPOSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 15 payments from 4 companies in 2025. Trend: 2023 $42 · 2024 $44 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $100 |
| Alkermes, Inc. | 4 | $78 |
| Teva Pharmaceuticals USA, Inc. | 3 | $77 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
Products named: INGREZZA, ARISTADA, UZEDY, COBENFY.
Industry payments across CA — which companies pay providers there.
